We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Samsung NeuroLogica to Operate Digital Radiography and Ultrasound Business Under New Brand

By MedImaging International staff writers
Posted on 08 Mar 2022
Print article
Image: Boston Imaging to commercialize Samsung DR and US imaging products in USA (Photo courtesy of Boston Imaging)
Image: Boston Imaging to commercialize Samsung DR and US imaging products in USA (Photo courtesy of Boston Imaging)

NeuroLogica Corp., the U.S. healthcare subsidiary of Samsung (Suwon-si, South Korea), has announced that the company’s digital radiography and ultrasound (DR & US) business will operate under a new brand called Boston Imaging (Danvers, MA, USA).

Boston Imaging markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. Boston Imaging is the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. Boston Imaging’s growing portfolio of advanced medical technologies is used in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction and increase workflow efficiency.

“This is a momentous day for the company, as it will allow us even greater focus on our core expertise, providing the U.S. market with innovative, best-in-class Digital Radiography and Ultrasound imaging devices with Samsung healthcare technology at the core,” said David Legg, Vice President, Ultrasound and Digital Radiography, Boston Imaging. “As we continue gaining market leadership, this change will also allow Boston Imaging to have a more dedicated focus for growing the business.”

“The Samsung name is synonymous with industry-leading imaging technology,” said Legg. “In the healthcare imaging market, Samsung is the only true technology company that is now in healthcare imaging, while competitors come from industrial roots that have pursued healthcare as an add-on business. This company specializes in delivering exquisite imaging results.”

“Our new brand, Boston Imaging, reinforces the strength of our legacy and signals the potential of our future,” added Legg. “Our past advancements and achievements within the two modalities include the current introduction of innovative products such as the V8 Ultrasound system and artificial intelligence solutions, like Auto Lung Nodule Detection (ALND) tool, in Digital Radiography.”

“Boston Imaging’s team mission is improving patient care by developing outstanding, customer-centric imaging solutions quickly and with passion. We remain committed to our vision of making the world a healthier place by empowering clinicians to diagnose their patients more confidently, quickly and cost-effectively,” said Legg. “We will continue to maintain our normal business operations and operating structure. The legal entity and name of the company remains NeuroLogica Corp. We will be Doing Business As (DBA), Boston Imaging. The mobile computed tomography (CT) business will continue to operate under the existing company name, NeuroLogica.”

Related Links:
Samsung 
Boston Imaging 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Remote Controlled Digital Radiography and Fluoroscopy System
Eco Track-DRF - MARS 50/MARS50+/MARS 65/MARS 80
Computed Tomography (CT) Scanner
Aquilion Serve SP
New
Pre-Op Planning Solution
Sectra 3D Trauma

Print article

Channels

Ultrasound

view channel
Image: Microscopic heart vessels have been imaged in super-resolution for the first time (Photo courtesy of Imperial College)

Super-Resolution Imaging Technique Could Improve Evaluation of Cardiac Conditions

The heart depends on efficient blood circulation to pump blood throughout the body, delivering oxygen to tissues and removing carbon dioxide and waste. Yet, when heart vessels are damaged, it can disrupt... Read more

Nuclear Medicine

view channel
Image: Whole-body maximum-intensity projections over time after [68Ga]Ga-DPI-4452 administration (Photo courtesy of SNMMI)

New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients

Clear cell renal cell cancer (ccRCC) represents 70-80% of renal cell carcinoma cases. While localized disease can be effectively treated with surgery and ablative therapies, one-third of patients either... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more